Portland, OR, Feb. 14, 2023 (GLOBE NEWSWIRE) -- According to the report published by Allied Market Research, the global Vertebroplasty And Kyphoplasty Market generated $757.1 million in 2021, and is estimated to reach $1.3 billion by 2031, witnessing a CAGR of 5.6% from 2022 to 2031. The report offers a detailed analysis of changing market trends, top segments, key investment pockets, value chains, regional landscape, and competitive scenario. The report is a helpful source of information for leading market players, new entrants, investors, and stakeholders in devising strategies for the future and taking steps to strengthen their position in the market.
Download Free Sample Report: https://www.alliedmarketresearch.com/request-sample/10809
Report coverage & details:
| Report Coverage | Details |
| Forecast Period | 2022–2031 |
| Base Year | 2021 |
| Market Size in 2021 | $757.1 Million |
| Market Size in 2031 | $1.3 Billion |
| CAGR | 5.6% |
| No. of Pages in Report | 183 |
| Segments Covered | Product, End User, and Region |
| Drivers | Rise in adoption of minimally invasive surgeries |
| Rise in incidence of spinal disorders among the population due to various factors, such as age and accidental injuries | |
| Increase in geriatric population | |
| High potential in untapped emerging markets due to availability of improved healthcare infrastructure | |
| Rise in demand for enhanced healthcare services and effective surgical techniques | |
| Development of the medical tourism industry in emerging countries | |
| Increase in promotional activities by manufacturers | |
| Opportunities | Surge in investments by government in developed countries to improve healthcare infrastructure |
| Restraints | High cost associated with the procedures and lack of reimbursement policies to avoid coverage for such costly devices in emerging countries |
Covid-19 Scenario:
- The COVID-19 pandemic outbreak had a negative impact on the growth of the vertebroplasty and kyphoplasty market, owing to disruption in workflows in the healthcare sector. The disease made several sub-domains of healthcare to shut their doors temporarily.
- The global vertebroplasty and kyphoplasty market witnessed a slowdown in 2020 due to global economic recession led by the COVID-19 pandemic. Moreover, the pandemic disrupted the supply chain across various end-user industries including healthcare.
- However, the market started recovering since 2021 and is expected to exhibit a stable growth in the future.
The report offers a detailed segmentation of the global vertebroplasty and kyphoplasty market based on product, end user, and region. The report provides an analysis of each segment and sub-segment with the help of tables and figures. This analysis helps market players, investors, and new entrants in determining the sub-segments to be tapped on to achieve growth in the coming years.
Purchase Inquiry: https://www.alliedmarketresearch.com/purchase-enquiry/10809
Based on product, the kyphoplasty segment held the largest share in 2021, accounting for nearly four-fifths of the global vertebroplasty and kyphoplasty market, and would maintain its dominance through 2031. Moreover, the same segment is estimated to witness the fastest CAGR of 5.9% during the forecast period. The report also provides an analysis of the vertebroplasty segment.
Based on end user, the hospitals segment held the largest share in 2021, capturing nearly four-fifths of the global vertebroplasty and kyphoplasty market, and would lead the trail through 2031. The ambulatory surgical centers segment is estimated to witness the fastest CAGR of 6.4% during the forecast period.
Based on region, the market in North America was the largest in 2021, accounting for nearly three-fifths of the global vertebroplasty and kyphoplasty market share, and is likely to maintain its leadership status during the forecast period. However, the market in Asia-Pacific is expected to manifest the highest CAGR of 7.9% from 2022 to 2031. The other regions analyzed in the study include Europe and LAMEA.
Leading players of the global vertebroplasty and kyphoplasty market analyzed in the research include Johnson and Johnson (DePuy Synthes), Medtronic Plc, Globus Medical Inc, Halma plc, Zavation LLC, BPB MEDICA - BIOPSYBELL, Merit Medical Systems Inc., Seawon Meditech, Joimax GmbH, and Stryker Corporation.
The report analyzes these key players of the global vertebroplasty and kyphoplasty market. These players have adopted various strategies such as expansion, new product launches, partnerships, and others to increase their market penetration and strengthen their position in the industry. The report is helpful in determining the business performance, operating segments, product portfolio, and developments by every market player.
Trending Reports in Healthcare Industry (Book Now with 10% Discount):
Digital Health Market by Product & Service (mHealth and eHealth), Component (Software, Hardware, and Services), and End User (Healthcare Providers, Payers, Healthcare Consumers, and Others): Global Opportunity Analysis and Industry Forecast, 2021-2030
Bronchoscopy Market by Product (Endoscope, Visualization & Documentation Systems, Accessories, and Other Products), Usability (Disposable Equipment and Reusable Equipment), Application (Bronchial Diagnosis and Bronchial Treatment), and End User (Hospitals and Ambulatory Surgical Centers & Clinics): Global Opportunity Analysis and Industry Forecast, 2021-2030
Gene Editing Market By Technology (Zinc Finger Nucleases (ZFNs), Transcription Activator-Like Effector-based Nucleases (TALENs), CRISPR-Cas9 Gene Editing, Restriction Enzymes, Others), By Application (Gene editing, Cell Line Engineering, Animal Genetic Engineering, Plant Genetic Engineering, Drug development, Others), By End User (Biotechnology and Pharmaceutical Companies, Academic and Government Research Institutes, Contract Research Organizations): Global Opportunity Analysis and Industry Forecast, 2021-2031
Brachytherapy Market By Product Type (Seeds, Applicators and Afterloaders, Electronic Brachytherapy), By Technique (High Dose Rate (HDR), Low Dose Rate (LDR)), By Application (Gynecological Cancer, Prostate Cancer, Breast Cancer, Others), By End User (Hospitals, Specialty Clinics, Others): Global Opportunity Analysis and Industry Forecast, 2021-2031
Stem cell therapy Market by Cell Source (Adipose Tissue-Derived Mesenchymal Stem Cells, Bone Marrow-Derived Mesenchymal Stem Cells, Cord Blood/Embryonic Stem Cells, Other), by Application (Cancer, Musculoskeletal Disorder, Wounds and Injuries, Cardiovascular Disease, Other), by Type (Allogeneic Transplants, Autologous Transplants): Global Opportunity Analysis and Industry Forecast, 2021-2031
About Us
Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions." AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.
We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Allied Market Research CEO Pawan Kumar is instrumental in inspiring and encouraging everyone associated with the company to maintain high quality of data and help clients in every way possible to achieve success. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.
